DUBLIN, September 29, 2021--(BUSINESS WIRE)--The "Global Hyaluronic Acid Market Research Report: Forecast (2021-2026)" report has been added to ResearchAndMarkets.com's offering.
The market is expected to grow at a CAGR of around 8% between 2021-2026
The growth of the Global Hyaluronic Acid Market is mounting to the aging population because of their joint pain and the rising prevalence of gingivitis and ulcers. Other factors like rising incidences of orthopedic diseases due to growth in the number of people suffering from obesity and the demand for the minimally invasive procedure project to grow in the hyaluronic acid market globally in the upcoming years.
The outbreak of the COVID-19 pandemic has brought the entire healthcare industry into the limelight and subsequently impacted the hyaluronic acid market. This downfall is due to a severe shortage of critical medical supplies and a rapid rise in COVID-19 cases. It further created a gap between the demand and supply of the market.
The stringent social distancing norms and restriction on movements appear to be an immediate effect on the market. However, post-COVID-19 lockdown, Hyaluronic Acid companies have started to strategize R&D investments and planning developing new products to enhance the performance and optimize the cost structure. Thus, the market is likely to grow substantially during the forecast period.
Cosmetic Grades Held the Largest Market Share
Based on the grade, the market classifies into cosmetic, pharmaceutical, and food grades. Among these grades, Cosmetic acquired the largest market share in the Global Hyaluronic Acid Market in 2019 owing to the launch of extensive hyaluronic-based cosmetic products, lifestyle changes, rising consumption of unhealthy food, and increasing pollution leading to skin disorders. Therefore, it is further presumed to drive the cosmetic grade segment growth in the Hyaluronic Acid market soon, reveals the author in their research report, Global Hyaluronic Acid Market Analysis, 2021.
The Osteoarthritis Segment Likely to show Substantial Growth
Based on the application, the osteoarthritis segment is likely to witness the fastest growth between 2021-26 that attributes to a significant surge in the geriatric population, which is more susceptible to joints & bone issues. However, the increasing orthopedic problems tend to form degenerative-joint disorders due to wear & tear of the joint over time. Hence, the demand for hyaluronic acid-based products upsurge in the coming years, states the author in their research report, Global Hyaluronic Acid Market Analysis, 2021.
Asia-Pacific is likely to grow considerably in the Global Hyaluronic Acid market during the forecast period. Japan likely to have the fastest growth as the country has numerous aged populations in the world.
The demand for hyaluronic acid shall propel as bone-related problems are likely to be the highest soon. Moreover, constant change in healthcare services and an increase in R&D activities would drive the extension of the hyaluronic acid market in the forecast period.
The upsurge in the geriatric population is boosting the market growth.
The burgeoning number of aging populations is one of the prevalent factors driving the growth of the hyaluronic market. The elderly population is vulnerable to orthopedic problems like arthritis and osteoporosis, which increases the need for treatment, including hyaluronic acid. According to WHO, the world population above the 60s will double from 12% to 22% between 2015-2050. Hence, it is likely to fuel the market growth in the forecast period.
The major leading players in the Global Hyaluronic Acid Market are Allergan Plc, Anika Therapeutics Inc, Sanofi, Fidia Farmaceutici, Seikagaku Corporation, Ferring Pharmaceuticals, Contipro Corporation, Kewpie Corporation, etc.
4. Impact of COVID-19 on Global Hyaluronic Acid Market
5. Global Hyaluronic Acid Market Dynamics
6. Global Hyaluronic Acid Market Policies and Product Standards
7. Global Hyaluronic Acid Market Trends & Insights
8. Global Hyaluronic Acid Market Hotspot & Opportunities
9. Global Hyaluronic Acid Market Key Strategic Imperatives for Success & Growth
10. Global Hyaluronic Acid Market Outlook, 2016-2026F
11. North America Hyaluronic Acid Market Outlook, 2016-2026F
11.3. The US Hyaluronic Acid Market Outlook, 2016-2026F
11.4. Canada Hyaluronic Acid Market Outlook, 2016-2026F
12. South America Hyaluronic Acid Market Outlook, 2016-2026F
13. Europe Hyaluronic Acid Market Outlook, 2016-2026F
14. Middle East & Africa Hyaluronic Acid Market Outlook, 2016-2026F
15. Asia-Pacific Hyaluronic Acid Market Outlook, 2016-2026F
16.2. Company Profiles of Top Companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
For more information about this report visit https://www.researchandmarkets.com/r/n3i08z
View source version on businesswire.com: https://www.businesswire.com/news/home/20210929005383/en/
ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Yahoo Finance Live anchors discuss stock performance for FedEx.
In this article, we discuss 10 high-yield dividend stocks for stable income. You can skip our detailed analysis of dividend stocks and their performance in the past, go directly and read 5 High-Yield Dividend Stocks for Stable Income. Dividend-paying stocks are gaining traction this year as investors look for cash during difficult times. Blue chip stable […]
There was a sell-off in cardboard packaging stocks this morning, with shares of International Paper (NYSE: IP) down 9.4% at 10:30 a.m. ET on Friday, Packaging Corporation of America (NYSE: PKG) shares down 9.7%, and the stock of WestRock (NYSE: WRK) down 9.8%. Shares of FedEx (NYSE: FDX) plunged more than 22% this morning after the company issued an earnings warning predicated on softening global volume. The volume FedEx referred to was the number of packages wrapped in cardboard and shipped to customers.
Electric vehicle (EV) stocks have gotten a lot of attention over the last few years as production has increased and multiple companies have come public, but that doesn't mean all EV stocks are good investments. Companies still have to make money building and selling vehicles, which has historically been the hardest part of the auto business. Given the current trends, I think General Motors (NYSE: GM) is the one EV stock to buy hand over fist, while ChargePoint (NYSE: CHPT) and Canoo (NASDAQ: GOEV) have some serious red flags.
Today's video focuses on KLA (NASDAQ: KLAC), Lam Research (NASDAQ: LRCX), Applied Materials (NASDAQ: AMAT), and recent reports of upcoming regulations affecting these semiconductor companies. The video also discusses Intel's (NASDAQ: INTC) forthcoming data center solution and how it might not be as competitive as investors hoped.
FedEx has blown three tires before the peak holiday shipping season, and chatter on the Street is that mighty Amazon may have played a role.
Warren Buffett, Berkshire Hathaway's (NYSE: BRK.A)(NYSE: BRK.B) chief executive officer and chairman, has been investing since the age of 11. With his net worth at nearly $100 billion, the understatement of the century would be to say that Buffett knows a thing or two about investing. This is why it's worth paying attention to the holdings within Berkshire Hathaway's $344 billion investment portfolio.
‘Nobody is buying this new experience cr**,’ wrote one staff member
Even the very profitable Tesla is getting incentives to help convert more Americans to electric vehicles.
Warren Buffett's Berkshire Hathaway is about to lose one of its higher-yielding dividend stocks. STORE Capital (NYSE: STOR), a real estate investment trust (REIT) with a high dividend yield, has agreed to be taken private by GIC and Oak Street. Because of that, Berkshire and other investors relying on STORE to supply them with passive income will need to find a replacement.
Looking for high yield stocks in the finance sector? This pair of banks is worth close inspection, while this REIT is best avoided.
Jefferies Equity Research Analyst Brent Thill assesses Adobe's deal to acquire Figma amid its third-quarter revenue beat, while looking at investor responses, the climate of the tech sector, and Amazon's NFL streaming deal.
While the latest federal moves on student loan forgiveness have some wrinkles, your journey to college debt clarity can still be smooth.
'He has gotten nowhere,' said West's lawyer about his attempts to work through partnership issues
You can't guess the bottom. But a bargain is a bargain.
The S&P 500 is forming a bottom, says one technical analysis expert.
High-yield savings accounts are paying far higher rates than before, and some come with a cash bonus.
Broadcom Inc. (AVGO) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
(Bloomberg) -- Former Treasury Secretary Lawrence Summers argued against the Federal Reserve holding back from aggressive monetary tightening, saying that greater economic damage would result from any hesitation.Most Read from BloombergGermany Tightens Control Over Industry With Russian Oil GrabJeff Bezos Loses Spot as World’s Second Richest Person to Gautam AdaniPatagonia Billionaire Who Gave Up Company Skirts $700 Million Tax HitAdobe Near Deal for Online Design Startup Figma, Sources SayPutin
Pound sinks to lowest since 1985 as retail sales slump Germany seizes control of three Russian-owned Rosneft oil refineries FTSE 100 falls 0.6pc Ben Marlow: Shell must accept it has lost the battle on fossil fuels Sign up here for our daily business briefing newsletter